CAS 1404-15-5
:Nogalamicina
Descrição:
Nogalamicina é um antibiótico antraciclínico de ocorrência natural que é derivado da bactéria *Micromonospora* espécies. É caracterizado por sua complexa estrutura policíclica, que inclui um componente de açúcar e um componente aglicona, contribuindo para sua atividade biológica. Nogalamicina exibe potentes propriedades antitumorais, principalmente através de sua capacidade de intercalar no DNA, interrompendo os processos de replicação e transcrição, o que leva, em última instância, à morte celular. Seu mecanismo de ação é semelhante ao de outras antraciclinas, como a doxorrubicina, mas possui um perfil único que pode oferecer vantagens em certos contextos terapêuticos. O composto mostrou atividade contra várias linhagens celulares de câncer, tornando-se um assunto de interesse na pesquisa do câncer. No entanto, como muitos agentes quimioterápicos, também pode exibir citotoxicidade para células normais, exigindo consideração cuidadosa nas aplicações clínicas. A pesquisa continua a explorar seus potenciais usos, estratégias de dosagem ideais e maneiras de mitigar os efeitos colaterais associados ao seu uso na terapia do câncer.
Fórmula:C39H49NO16
InChI:InChI=1S/C39H49NO16/c1-14-32(49-7)39(4,52-10)33(50-8)36(53-14)54-19-13-37(2,48)24(34(47)51-9)15-11-16-21(27(43)20(15)19)28(44)22-18(41)12-17-30(23(22)26(16)42)55-35-29(45)25(40(5)6)31(46)38(17,3)56-35/h11-12,14,19,24-25,29,31-33,35-36,41,43,45-46,48H,13H2,1-10H3/t14-,19-,24-,25-,29-,31+,32-,33-,35+,36-,37-,38+,39+/m0/s1
Chave InChI:InChIKey=KGTDRFCXGRULNK-JYOBTZKQSA-N
SMILES:O=C1C=2C3=C([C@@]4(C)O[C@@](O3)([C@@H](O)[C@H](N(C)C)[C@H]4O)[H])C=C(O)C2C(=O)C=5C1=CC6=C(C5O)[C@@H](O[C@H]7[C@H](OC)[C@@](OC)(C)[C@@H](OC)[C@H](C)O7)C[C@](C)(O)[C@@H]6C(OC)=O
Sinónimos:- 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha))-
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, [2R-(2α,3β,4α,5β,6α,11β,13α,14α)]-
- Antibiotic 205t3
- Antibiotic NSC 70845
- Antibiotic from Streptomyces nogalater
- Methyl 11-((6-desoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-dimethylamino-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno(1,2-b)-oxocin-14-carboxylat
- Nogalamicina
- Nogalamicina [INN-Spanish]
- Nogalamycin [USAN:INN]
- Nogalamycine
- Nogalamycine [INN-French]
- Nogalamycinum
- Nogalamycinum [INN-Latin]
- Nogalamyicn
- Nogalomycin
- Nsc 70845
- U 15167
- methyl (2R,3S,4R,5R,6R,11S,13S,14R)-11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- methyl (2S,3S,4R,5R,6S,11S,13S,14R)-11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- methyl 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- Nogalamycin
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, [2R-(2α,3β,4α,5β,6α,11β,13α,14α)]-
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produtos.
2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
CAS:Fórmula:C39H49NO16Pureza:97%Cor e Forma:SolidPeso molecular:787.8035Nogalamycin
CAS:Nogalamycin is an anthracycline antibiotic with antitumor properties produced by soil bacteria Streptomyces nogalater.Fórmula:C39H49NO16Pureza:98%Cor e Forma:SolidPeso molecular:787.812Nogalamycin
CAS:Produto Controlado<p>Applications Nogalamycin (cas# 1404-15-5) is a compound useful in organic synthesis.<br></p>Fórmula:C39H49NO16Cor e Forma:NeatPeso molecular:787.803



